open Ethanol [ppbV] Acetone [ppbV] Isopropanol [ppbV] DMS [ppbV] Isoprene [ppbV] Pentanal [ppbV] Limonen [ppbV] Controls 82.4 a,b,c (20.7-554) 232* (186-306) 784 a,b (287-28,963) 10.0 a,b,c (0.99-151) 49.6 a,b,c (7.44-153) 5.30 a,b,c (1.36-36.9) 51.8 (4.81-1,192) Patients 171 a (44. Table 1 . Exhaled amounts of selected alveolar VOCs in the study population. Data is given as median and range. Superscripts denote significantly different concentrations of the respective analytes between identically labelled groups. DMS, dimethylsulfide. a controls vs patients: p < 0.001 for ethanol, DMS, isoprene, and pentanal, p = 0.002 for isopropanol; b controls vs patients with good metabolic control (HbA 1c < 8%): p < 0.001 for ethanol, DMS, isoprene, and pentanal; c controls vs patients with poor metabolic control (HbA 1c > 8%): p < 0.001 for ethanol, isopropanol, isoprene, and pentanal, p = 0.03 for DMS; d patiens with poor vs those with good metabolic control: p < 0.001 for isopropanol and p = 0.012 for pentanal.
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